Article
Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report.
Pharmacogenomics - 1 Sept 2013
Laurenty Anne-Pascale, Thomas Fabienne, Chatelut Etienne, Bétrian Sarah, Le Guellec Chantal, Hennebelle Isabelle, Le Guellec Sophie, Chevreau Christine
Abstract excerpt
We describe here the case of a 60-year old male patient treated for an extensive local progression of a pleiomorphic sarcoma on the right tibial crest with second-line trabectedin. Two cycles were administrated before a major liver toxicity was retrieved, with both cytolytic and cholestatic hepatitis quickly associated with irreversible jaundice. The radiological, histological, chemistry and pharmacogenetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
